Peter Kufer

Person

Munich, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3
- Patent number 12,152,078
- Issue date Nov 26, 2024
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific single domain bispecific single chain antibody
- Patent number 11,987,633
- Issue date May 21, 2024
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions comprising cross-species-specific antibodies and uses...
- Patent number 11,925,684
- Issue date Mar 12, 2024
- Amgen Research (Munich) GmbH
- Roman Kischel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody constructs for CDH3 and CD3
- Patent number 11,926,666
- Issue date Mar 12, 2024
- Amgen Research (Munich) GmbH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for MSLN and CD3
- Patent number 11,884,720
- Issue date Jan 30, 2024
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Optimized cross-species specific bispecific single chain antibody c...
- Patent number 11,661,462
- Issue date May 30, 2023
- Amgen Research (Munich) GmbH
- Benno Rattel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for DLL3 and CD3
- Patent number 11,591,396
- Issue date Feb 28, 2023
- Amgen Research (Munich) GmbH
- Tobias Raum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 11,498,964
- Issue date Nov 15, 2022
- Amgen Research (Munich) GmbH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific PSMAxCD3 bispecific single chain antibody
- Patent number 11,472,886
- Issue date Oct 18, 2022
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific T cell engaging antibody constructs
- Patent number 11,434,302
- Issue date Sep 6, 2022
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCMA and CD3 bispecific T cell engaging antibody constructs
- Patent number 11,352,433
- Issue date Jun 7, 2022
- Amgen Research (Munich) GmbH
- Tobias Raum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Means and methods for the treament of B cell non-hodgkin lymphoma a...
- Patent number 11,154,617
- Issue date Oct 26, 2021
- Amgen Research (Munich) GmbH
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating glioblastoma or glioma with antibody constructs...
- Patent number 11,155,629
- Issue date Oct 26, 2021
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-leukocyte adhesion for the mitigation of potential adverse eve...
- Patent number 11,084,876
- Issue date Aug 10, 2021
- Amgen Research (Munich) GmbH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Risk-stratification of B-precursor acute lymphoblastic leukemia pat...
- Patent number 11,079,381
- Issue date Aug 3, 2021
- Amgen Research (Munich) GmbH
- Gerhard Zugmaier
- G01 - MEASURING TESTING
Information Patent Grant
Administration of a bispecific construct binding to CD33 and CD3 fo...
- Patent number 11,053,318
- Issue date Jul 6, 2021
- Amgen Research (Munich) GmbH
- Gerhard Zugmaier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody constructs for CDH3 and CD3
- Patent number 11,028,171
- Issue date Jun 8, 2021
- Amgen Research (Munich) GmbH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific single domain bispecific single chain antibody
- Patent number 10,981,998
- Issue date Apr 20, 2021
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PSMA and CD3 bispecific T cell engaging antibody constructs
- Patent number 10,781,264
- Issue date Sep 22, 2020
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 10,766,969
- Issue date Sep 8, 2020
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 10,752,694
- Issue date Aug 25, 2020
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for DLL3 and CD3
- Patent number 10,683,351
- Issue date Jun 16, 2020
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage regimen for administering a CD19XCD3 bispecific antibody
- Patent number 10,662,243
- Issue date May 26, 2020
- Amgen Research (Munich) GmbH
- Dirk Nagorsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for EGFRVIII and CD3
- Patent number 10,519,241
- Issue date Dec 31, 2019
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BCMA and CD3 bispecific T cell engaging antibody constructs
- Patent number 10,301,391
- Issue date May 28, 2019
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for DLL3 and CD3
- Patent number 10,294,300
- Issue date May 21, 2019
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 10,059,766
- Issue date Aug 28, 2018
- Amgen Inc.
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific single chain antibodies with specificity for high molecu...
- Patent number 10,047,159
- Issue date Aug 14, 2018
- Amgen Research (Munich) GmbH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 9,982,063
- Issue date May 29, 2018
- Amgen Research (Munich) GmbH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 9,765,157
- Issue date Sep 19, 2017
- Amgen Research (Munich) GmbH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY CONSTRUCTS FOR MSLN AND CD3
- Publication number 20240400673
- Publication date Dec 5, 2024
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SE...
- Publication number 20240209078
- Publication date Jun 27, 2024
- Amgen Inc.
- Stephanie Everts
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Single chain binding molecules comprising N-terminal ABP
- Publication number 20240166761
- Publication date May 23, 2024
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Constructs for CDH19 and CD3
- Publication number 20240010724
- Publication date Jan 11, 2024
- Amgen Inc.
- Shouhua Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR ADMINISTERING THERAPEUTIC DOSES OF BISPECIFIC T-CELL EN...
- Publication number 20230398147
- Publication date Dec 14, 2023
- Amgen Inc.
- Adam B. MCCULLOUGH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC BINDING DOMAIN
- Publication number 20230357444
- Publication date Nov 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONSTRUCTS FOR DLL3 AND CD3
- Publication number 20230312717
- Publication date Oct 5, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS
- Publication number 20230192884
- Publication date Jun 22, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LONG LIFE POLYPEPTIDE BINDING MOLECULES
- Publication number 20230057728
- Publication date Feb 23, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20230037742
- Publication date Feb 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3
- Publication number 20230041876
- Publication date Feb 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE D...
- Publication number 20220403035
- Publication date Dec 22, 2022
- Jonas Anlahr
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220356268
- Publication date Nov 10, 2022
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220251243
- Publication date Aug 11, 2022
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Means and Methods for Treating Tumorous Diseases
- Publication number 20220088196
- Publication date Mar 24, 2022
- AMGEN RESEARCH (MUNICH) GMBH
- Patrick Bauerle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING GLIOBLASTOMA OR GLIOMA WITH ANITBODY CONSTRUCTS...
- Publication number 20220064308
- Publication date Mar 3, 2022
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220064336
- Publication date Mar 3, 2022
- Amgen Inc.
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC SINGLE DOMAIN BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20220041736
- Publication date Feb 10, 2022
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONSTRUCTS FOR DLL3 AND CD3
- Publication number 20210309743
- Publication date Oct 7, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROLONGED ADMINISTRATION OF A BISPECIFIC ANTIBODY CONSTRUCT BINDING...
- Publication number 20210301017
- Publication date Sep 30, 2021
- Dirk Nagorsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20210277143
- Publication date Sep 9, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20210269550
- Publication date Sep 2, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs
- Publication number 20210070878
- Publication date Mar 11, 2021
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD...
- Publication number 20200362039
- Publication date Nov 19, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONSTRUCTS FOR DLL3 AND CD3
- Publication number 20200332002
- Publication date Oct 22, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3
- Publication number 20200140558
- Publication date May 7, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
- Publication number 20200095319
- Publication date Mar 26, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONSTRUCTS FOR CDH19 AND CD3
- Publication number 20200071405
- Publication date Mar 5, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS
- Publication number 20200048357
- Publication date Feb 13, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Single chain binding molecules comprising N-terminal ABP
- Publication number 20200040099
- Publication date Feb 6, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY

Peter Kufer

Person

Patents Grantslast 30 patents

Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3

Cross-species-specific single domain bispecific single chain antibody

Compositions comprising cross-species-specific antibodies and uses...

Bispecific antibody constructs for CDH3 and CD3

Antibody constructs for MSLN and CD3

Optimized cross-species specific bispecific single chain antibody c...

Antibody constructs for DLL3 and CD3

Antibody constructs for CDH19 and CD3

Cross-species-specific PSMAxCD3 bispecific single chain antibody

Bispecific T cell engaging antibody constructs

BCMA and CD3 bispecific T cell engaging antibody constructs

Means and methods for the treament of B cell non-hodgkin lymphoma a...

Method for treating glioblastoma or glioma with antibody constructs...

Anti-leukocyte adhesion for the mitigation of potential adverse eve...

Risk-stratification of B-precursor acute lymphoblastic leukemia pat...

Administration of a bispecific construct binding to CD33 and CD3 fo...

Bispecific antibody constructs for CDH3 and CD3

Cross-species-specific single domain bispecific single chain antibody

PSMA and CD3 bispecific T cell engaging antibody constructs

Binding molecules for BCMA and CD3

Binding molecules for BCMA and CD3

Antibody constructs for DLL3 and CD3

Dosage regimen for administering a CD19XCD3 bispecific antibody

Antibody constructs for EGFRVIII and CD3

BCMA and CD3 bispecific T cell engaging antibody constructs

Antibody constructs for DLL3 and CD3

Antibody constructs for CDH19 and CD3

Bispecific single chain antibodies with specificity for high molecu...

Pharmaceutical compositions with resistance to soluble CEA

Antibody constructs for CDH19 and CD3

Patents Applicationslast 30 patents

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SE...

Single chain binding molecules comprising N-terminal ABP

Antibody Constructs for CDH19 and CD3

METHODS FOR ADMINISTERING THERAPEUTIC DOSES OF BISPECIFIC T-CELL EN...

CROSS-SPECIES-SPECIFIC BINDING DOMAIN

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

LONG LIFE POLYPEPTIDE BINDING MOLECULES

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE D...

BINDING MOLECULES FOR BCMA AND CD3

BINDING MOLECULES FOR BCMA AND CD3

Means and Methods for Treating Tumorous Diseases

METHOD FOR TREATING GLIOBLASTOMA OR GLIOMA WITH ANITBODY CONSTRUCTS...

BINDING MOLECULES FOR BCMA AND CD3

CROSS-SPECIES-SPECIFIC SINGLE DOMAIN BISPECIFIC SINGLE CHAIN ANTIBODY

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

PROLONGED ADMINISTRATION OF A BISPECIFIC ANTIBODY CONSTRUCT BINDING...

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD...

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3

BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

Single chain binding molecules comprising N-terminal ABP